StockData
Acumen Pharmaceuticals, Inc. logo

Acumen Pharmaceuticals, Inc. (ABOS) stock

ABOSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 2/30
$0.23+0.01 (+6.53%)

Close on Nov 17, 2026Market cap $16.64MP/E –Yield –

Acumen Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Acumen Pharmaceuticals's price to book ratio was 0.3× on Nov 11, 2026, against 1.2× a year earlier. Over the last 5 years it ranged from 0.3× to 3.6×, with a median of 0.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.3×−1.1
2025Dec 31, 20251.4×+0.9
2024Dec 31, 20240.5×−0.3
2023Dec 29, 20230.8×−0.3
2022Dec 30, 20221.1×−0.1
2021Dec 31, 20211.2×–

More Acumen Pharmaceuticals figures

See a number that looks wrong?